<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04643288</url>
  </required_header>
  <id_info>
    <org_study_id>nano version 1</org_study_id>
    <nct_id>NCT04643288</nct_id>
  </id_info>
  <brief_title>Nanocrystalline Hydroxyapatite Bone Substitute for Treating Periodontal Intrabony Defects</brief_title>
  <official_title>Clinical and Radiographic Evaluation of Open Flap Debridement With or Without Nanocrystalline Hydroxyapatite Bone Graft in Management of Periodontal Intrabony Defects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Weam Ahmed Elbattawy</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cairo University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The present clinical trial included 20 patients (11 females and 9 males, aged 36 to 56 years)&#xD;
      suffering from moderate or advanced chronic periodontitis. Subjects were recruited from the&#xD;
      outpatient clinic, Department of Oral Medicine and Periodontology, Faculty of Dentistry,&#xD;
      Cairo University. This clinical trial was meant to assess clinically and radiographically the&#xD;
      possible predictable results regarding the use of nanocrystalline hydroxyapatite bone graft&#xD;
      substitute together with open flap debridement versus open flap debridement alone in the&#xD;
      treatment of periodontal intrabony defects.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      periodontal intrabony defects in patients with moderate or advanced chronic periodontitis&#xD;
      were treated with open flap debridement only in the control group while open flap debridement&#xD;
      and Nanocrystalline Hydroxyapatite bone graft substitute was performed for the intervention&#xD;
      group. probing pocket depth, clinical attachment level, gingival index, plaque index,&#xD;
      gingival recession and bone defect area were assessed at baseline and six months post&#xD;
      surgically to evaluate the possible improvement in the clinical and radiographic outcomes.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 1, 2018</start_date>
  <completion_date type="Actual">May 25, 2020</completion_date>
  <primary_completion_date type="Actual">November 25, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>change in probing pocket depth</measure>
    <time_frame>baseline and after six months</time_frame>
    <description>William's graduated periodontal probe used to measure probing pocket depth from the gingival margin to the base of the sulcus</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>change in clinical attachment level</measure>
    <time_frame>baseline and after six months</time_frame>
    <description>William's graduated periodontal probe used to measure clinical attachment level from the cementoenamel junction to the base of the sulcus</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change in the bone defect area</measure>
    <time_frame>baseline and after six months</time_frame>
    <description>periodical digital radiographs using Digora software to measure the bone defect area</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Chronic Periodontitis</condition>
  <arm_group>
    <arm_group_label>OFD control group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>open flap debridement for periodontal intrabony defects</description>
  </arm_group>
  <arm_group>
    <arm_group_label>n-HA bone graft intervention group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Nanocrystalline Hydroxyapatite (n-HA) bone graft substitute was added to periodontal intrabony defects</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>open flap debridement</intervention_name>
    <description>open flap debridement for managing two and three walls intrabony periodontal defects</description>
    <arm_group_label>OFD control group</arm_group_label>
    <arm_group_label>n-HA bone graft intervention group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>n-HA bone graft</intervention_name>
    <description>Nanocrystalline Hydroxyapatite bone graft substitute for managing two and three walls intrabony periodontal defects</description>
    <arm_group_label>n-HA bone graft intervention group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  systemically healthy patients&#xD;
&#xD;
          -  diagnosed with moderate to advanced chronic periodontitis&#xD;
&#xD;
          -  periodontal defects with at least one site with probing pocket depth (PPD) ≥ 5mm,&#xD;
             clinical attachment loss (CAL) ≥ 4mm and two or three-walled intra-bony defects ≥ 3mm&#xD;
&#xD;
          -  evidence of intrabony defects using periapical radiographs&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  teeth with suprabony defects or 1-wall intrabony defects&#xD;
&#xD;
          -  pregnant or lactating women&#xD;
&#xD;
          -  patients taking any medication 3 months prior to the study&#xD;
&#xD;
          -  patients receiving any periodontal treatment 6 months prior to study initiation&#xD;
&#xD;
          -  former or current smokers.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>56 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Cairo University</name>
      <address>
        <city>Cairo</city>
        <zip>11865</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>November 14, 2020</study_first_submitted>
  <study_first_submitted_qc>November 18, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 25, 2020</study_first_posted>
  <last_update_submitted>November 24, 2020</last_update_submitted>
  <last_update_submitted_qc>November 24, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 27, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Cairo University</investigator_affiliation>
    <investigator_full_name>Weam Ahmed Elbattawy</investigator_full_name>
    <investigator_title>Lecturer</investigator_title>
  </responsible_party>
  <keyword>periodontal intrabony defects</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Periodontitis</mesh_term>
    <mesh_term>Chronic Periodontitis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

